• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Protect Pharmaceutical Corporation has Acquired Top Notch Software Development Company

Share:

June 29, 2022

Protect Pharmaceutical Corporation (OTC:PRTT) has acquired the 100% of the shares of CJSC “Inaiapp”, a Belarusian developer of corporate software for business digitalization.

With 8 years of blockchain development experience and list of long term clients, Inaiapp will bring its qualification and management processes to a new level.

“Robotic process automation, AI systems and machine learning systems, blockchain-based solutions, Data Science tools for business growth – we closely follow global trends in IT technology and are now ready to create the most profitable solution for your business.” – says Nick Greb, President of PRTT.

PRTT offers range of services and software products, to solve painful problems.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

The company is using time-tested practices in the field of robotics, artificial intelligence, machine learning and blockchain, creating first-class solutions that meet current business needs.

“Now we will combine the US market presence with extensive technical expertise that enable us to develop products that accelerate and streamline business processes through autonomy, transparency and security.” – Nick adds.

Source: Biospace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • COVID-19: How Hospitals Can Create Better Inpatient Bed Capacity through MathCOVID-19: How Hospitals Can Create Better Inpatient Bed Capacity through Math
  • Mass General Brigham, AstraZeneca Discuss Making Pharma-Provider PartnershipsMass General Brigham, AstraZeneca Discuss Making Pharma-Provider Partnerships
  • Geisinger and Medial Earlysign Advance to First Stage of Cms Ai Health Outcomes ChallengeGeisinger and Medial Earlysign Advance to First Stage of Cms Ai Health Outcomes Challenge
  • Purdue Pharma, Accused Of Fueling Opioid Crisis, Files For Chapter 11Purdue Pharma, Accused Of Fueling Opioid Crisis, Files For Chapter 11
  • Summit Medical Group Oregon Adds Bend Urology AssociatesSummit Medical Group Oregon Adds Bend Urology Associates
  • Aleafia Health Increases Strategic Investment in Australian LP CannaPacificAleafia Health Increases Strategic Investment in Australian LP CannaPacific
  • Medical Supplies Market Future Adoption Overview 2025Medical Supplies Market Future Adoption Overview 2025
  • Discovery Life Sciences Acquires Targos to Create Market-Leading Global Tissue Biomarker ServicesDiscovery Life Sciences Acquires Targos to Create Market-Leading Global Tissue Biomarker Services

Trending This Week

  • Novartis Drops Eye Disease Gene Therapy from $800M Gyroscope Acquisition
  • GSAC Engineering Acquires Key Intellectual Property and Assets from Duos Technologies GroupGelStat’s Subsidiary, GSAC Engineering, Launches Intelligent Correctional Facilities Automation Systems (iCAS) in the Industrial Security Market
  • Life Launches AI Clinical Trial Matching Assistant for Cancer
  • 79% of Healthcare Execs Believe Most Drug Diversion Goes Undetected
  • Moonshot Client Axolotl Announces Merger with Carmell Therapeutics, Elevating the Field of Regenerative Medicine
  • FDA Releases Updated Final Guidance for its Breakthrough Devices Program

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications